Corrado Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,475
Closed -$127K 211
2022
Q4
$127K Buy
+1,475
New +$117K 0.09% 133
2018
Q1
Sell
-47,976
Closed -$3.44M 122
2017
Q4
$3.44M Sell
47,976
-2,295
-5% -$174K 2.01% 14
2017
Q3
$4.07M Sell
50,271
-695
-1% -$53.1K 2.29% 12
2017
Q2
$3.61M Sell
50,966
-318
-0.6% -$21.2K 1.98% 15
2017
Q1
$3.48M Sell
51,284
-470
-0.9% -$33K 2% 15
2016
Q4
$3.71M Sell
51,754
-18,796
-27% -$1.4M 2.3% 16
2016
Q3
$5.58M Buy
70,550
+2,997
+4% +$243K 3.56% 7
2016
Q2
$5.63M Sell
67,553
-4,683
-6% -$416K 3.66% 6
2016
Q1
$6.64M Sell
72,236
-1,322
-2% -$119K 4.25% 4
2015
Q4
$7.44M Sell
73,558
-7,373
-9% -$767K 4.38% 7
2015
Q3
$7.95M Sell
80,931
-2,646
-3% -$294K 4.5% 5
2015
Q2
$9.79M Buy
83,577
+19,255
+30% +$2.1M 4.41% 3
2015
Q1
$6.31M Buy
+64,322
New +$6.53M 2.73% 14

Other funds holding GILD

Corrado Advisors's GILD Position: Q1 2023 in Review

Corrado Advisors sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 1,475 shares — an estimated $127K sold.

Corrado Advisors first reported a position in GILD in Q1 2015 and held it in 13 quarters. The position peaked at $9.79M in Q2 2015. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Corrado Advisors reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Corrado Advisors sold 1,475 Gilead Sciences shares in Q1 2023, an estimated $127K.
  • Corrado Advisors first reported a position in Gilead Sciences in Q1 2015 and held it in 13 quarters.
  • Corrado Advisors's Gilead Sciences position peaked at $9.79M in Q2 2015.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Corrado Advisors's 13F filing for Q1 2023, filed 3 May 2023.